IL-4 and interferon-γ differentially modulate vascular endothelial growth factor release from normal human keratinocytes and fibroblasts

Experimental Dermatology

Volumn 11, Issue 3, 2002, Pages 224-231

  Trompezinski, S ^a   Denis, A ^b   Vinche, A ^b   Schmitt, D ^a   Viac, J ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b Société BIODERMA   (France)

Author keywords

Fibroblasts; IL 4; Interferon , growth factors; Keratinocytes; VEGF

Indexed keywords

EPIDERMAL GROWTH FACTOR; GAMMA INTERFERON; GROWTH FACTOR; INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN; ENDOTHELIAL CELL GROWTH FACTOR; LYMPHOKINE; SIGNAL PEPTIDE; TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CANCER INVASION; CELL ACTIVATION; CELL CULTURE; CELL STIMULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CULTURE MEDIUM; HUMAN; HUMAN CELL; INFLAMMATION; KERATINOCYTE; NONHUMAN; PREPUCE; PROTEIN EXPRESSION; PROTEIN SECRETION; SKIN FIBROBLAST; SKIN INFLAMMATION; TH1 CELL; WOUND HEALING; CYTOLOGY; DRUG EFFECT; FIBROBLAST; KINETICS; MALE; METABOLISM; NEWBORN; PHYSIOLOGY; SECRETION;

CELLS, CULTURED; ENDOTHELIAL GROWTH FACTORS; EPIDERMAL GROWTH FACTOR; FIBROBLASTS; HUMANS; INFANT, NEWBORN; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERFERON TYPE II; INTERLEUKIN-4; KERATINOCYTES; KINETICS; LYMPHOKINES; MALE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036616886     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0625.2002.110305.x     Document Type: Article

References (34)

1. Volpert O V, Fong T, Koch A E, et al. Inhibition of angiogenesis by interleukin-4. J Exp Med 1998: 188: 1039-1046.
2. Maheshwari R K, Srikantan V, Bhartiya D, Kleinman H K, Grant D S. Differential effects of interferon gamma and alpha on in vitro model of angiogenesis. J Cell Physiol 1991: 146: 164-169.
3. Norioka K, Mitaka T, Mochizuki Y, Hara M, Kawagoe M, Nakamura H. Interaction of interleukin-1 and interferon-gamma on fibroblast growth factor-induced angiogenesis. Jpn J Cancer Res 1994: 85: 522-529.
4. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocrine Rev 1997: 18: 4-25.
5. Barleon B, Sozzani S, Zhou D, Welch H A, Mantovani A, Marme D. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 1996: 87: 3336-3343.
6. Ballaun C, Weninger W, Uthman A, Weich H, Tschachler E. Human keratinocytes express the three major splice forms of vascular endothelial growth factor. J Invest Dermatol 1995: 104: 7-10.
7. Detmar M Yeo K T, Nagy J A et al. Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells. J Invest Dermatol 1995: 105: 44-50.
8. Vic J, Palacio S, Schmitt D, Claudy A. Expression of vascular endothelial growth factor in normal epidermis, epithelial tumors and cultured keratinocytes. Arch Dermatol Res 1997: 289: 158-163.
9. Frank S, Hübner G, Breier G, Longaker M T, Greenhalgh D G, Werner S. Regulation of vascular endothelial growth factor expression in cultured keratinocytes. J Biol Chem 1995: 270: 12607-12613.
10. Dermat M, Brown L F, Claffey K P et al. Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med 1994: 180: 1141-1146.
11. Brouty-Boye D, Zetter BR. Inhibition of cell motility by interferon. Science 1980: 208: 516-518.
12. Angiolillo AL, Sgadari C, Taub DD et al. Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J Exp Med 1995: 182: 155-162.
13. Zetter B R. Angiogenesis and tumor metastatis. Annu Rev Med 1998: 49: 407-424.
14. Trompezinski S, Pernet J, Mayoux C, Schmitt D, Viac J. Transforming growth factor-beta1 and ultraviolet A1 radiation increase production of vascular endothelial growth factor but not endothelin-1 in human fibroblasts. Br J Dermatol 2000: 143: 539-545.
15. Matsuura K, Otsuka F, Fujisawa H. Effects of interferons on tumour necrosis factor alpha production from human keratinocytes. Cytokine 1998: 10: 500-505.
16. Viac J, Guéniche A, Gatto H, Lizard G, Schmitt D. Interleukin-4 and interferon-γ interactions in the induction of intercellular adhesion molecule-1 and major histocompatibility complex class II antigen expression of normal human keratinocytes. Exp Dermatol 1994: 3: 72-77.
17. Albanesi C, Scarponi C, Sebastiani S et al. IL-4 enhances keratinocyte expression of CXCR3 agonistic chemokines. J Immunol 2000: 165: 1395-1402.
18. Sempowski G D, Dardak S, Phipps R P. Interleukin-4 and interferon-gamma discordantly regulate collagen biosynthesis by functionally distinct lung fibroblast subsets. J Cell Physiol 1996: 167: 290-296.
19. Serpier H, Gillery P, Salmon-Ehr V et al. Antagonistic effects of interferon-gamma and interleukin-4 on fibroblast cultures. J Invest Dermatol 1997: 109: 158-162.
20. Pertovaara L, Kaipainen A, Mustonen T et al. Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. J Biol Chem 1994: 269: 6271-6274.
21. Yokozeki M, Baba Y, Shimokawa H, Moriyama K, Kuroda T. Interferon-gamma inhibits the myofibroblastic phenotype of rat palatal fibroblasts induced by transforming growth factor-beta1 in vitro. FEBS Lett 1999: 442: 61-64.
22. Tredget E E, Wang R, Shen Q, Scott P G, Ghaharay A. Transforming growth factor-beta mRNA and protein in hypertrophic scar tissues and fibroblasts: Antagonism by IFN-alpha and IFN-gamma in vitro and in vivo. J Interferon Cytokines Res 2000: 20: 143-151.
23. Nickoloff B J, Mitra R S, Varani J, Dixit V M, Polverini P J. Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis. Am J Pathol 1994: 144: 820-828.
24. Gottlieb A B, Luster A D, Posnett D N, Carter D M. Detection of a gamma interferon-induced protein IP-10 in psoriatic plaques. J Exp Med 1988: 168: 941-948.
25. Nickoloff B J. Characterization of lymphocyte-dependent angiogenesis using a SCID mouse: Human skin model of psoriasis. J Invest Dermatol Symp Proc 2000: 5: 67-73.
26. Nickoloff B J. Cytokine network in psoriasis. Arch Dermatol 1991: 127: 871-884.
27. Malhotra R, Stenn K S, Fernandez L A, Braverman I M. Angiogenic properties of normal and psoriatic skin associate with epidermis, not dermis. Laboratory Invest 1989: 61: 162-165.
28. Brown L F, Olbritch S M, Berse B et al. Overexpression of vascular permeability factor (VPF/VEGF) and its endothelial cell receptors in delayed hypersensitivity skin reactions. J Immunol 1995: 154: 2801-2807.
29. Mitev V, Miteva L. Signal transduction in keratinocytes. Exp Dermatol 1999: 8: 96-108.
30. Matsumoto K, Ohi H, Kanmatsuse K. Interleukin-4 cooperates with interleukin-10 to inhibit vascular permeability factor release by peripheral blood mononuclear cells from patients with minimal-changed nephrotic syndrome. Am J Nephrol 1999: 19: 21-27.
31. Bottomley M J, Webb N J, Watson C J, Holt P J, Freemont A J, Brenchley P E. Peripheral blood mononuclear cells from patients with rheumatoid arthritis spontaneously secrete vascular endothelial growth factor (VEGF): Specific up-regulation by tumour necrosis factor-alpha (TNF-alpha) in synovial fluid. Clin Exp Immunol 1999: 117: 171-176.
32. Kawano Y, Matsui N, Kamihigashi S, Narahara H, Miyakawa I. Effect of interferon-gamma on secretion of vascular endothelial growth factor by endometrial stromal cells. Am J Reprod Immunol 2000: 43: 47-52.
33. Griga T, Hebler U, Voigt E, Tromm A, May B. Interleukin-4 inhibits the increased production of vascular endothelial growth factor by peripheral blood mononuclear cells in patients with inflammatory bowel disease. Hepatogastro-Enterology 2000: 47: 1604-1607.
34. Saunders N, Dahler A, Jones S, Smith R, Jetten A. Interferon-gamma as a regulator of squamous differentiation. J Dermatol Sci 1996: 13: 98-106.